Rankings
▼
Calendar
VSTM Q4 2019 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+198.8% YoY
Gross Profit
$3M
80.0% margin
Operating Income
-$33M
-920.7% margin
Net Income
-$39M
-1072.3% margin
EPS (Diluted)
$-6.09
QoQ Revenue Growth
-60.0%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$37M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$145M
Total Liabilities
$138M
Stockholders' Equity
$7M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$1M
+198.8%
Gross Profit
$3M
$1M
+164.4%
Operating Income
-$33M
-$34M
+2.8%
Net Income
-$39M
-$11M
-241.7%
Revenue Segments
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$2M
60%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$695,000
22%
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$544,000
18%
Product Revenue And Allowances Returns
$5,000
0%
← FY 2019
All Quarters
Q1 2020 →